Improved infrastructure and support needed for paediatric clinical trials in Sweden
(2020) In Acta Paediatrica, International Journal of Paediatrics 109(12). p.2740-2747- Abstract
Aim: There is a lack of authorised medicines for paediatric patients and improved drug development is necessary. The aim of this study was to evaluate the need for infrastructure and support for paediatric clinical trials in Sweden. Methods: A web-based survey was sent to doctors and nurses involved in the care of neonates, children and adolescents assessing the current situation and future needs for paediatric clinical trials in Sweden. Questions regarding premises, competence, organisation, support for paediatric clinical trials and Good Clinical Practice Training were addressed. Results: In total, 137 individuals responded to the survey (109 doctors and 28 nurses). Overall, 61% of the respondents had previous experience of paediatric... (More)
Aim: There is a lack of authorised medicines for paediatric patients and improved drug development is necessary. The aim of this study was to evaluate the need for infrastructure and support for paediatric clinical trials in Sweden. Methods: A web-based survey was sent to doctors and nurses involved in the care of neonates, children and adolescents assessing the current situation and future needs for paediatric clinical trials in Sweden. Questions regarding premises, competence, organisation, support for paediatric clinical trials and Good Clinical Practice Training were addressed. Results: In total, 137 individuals responded to the survey (109 doctors and 28 nurses). Overall, 61% of the respondents had previous experience of paediatric clinical trials. Some respondents had access to trial units, but only 34% had used the trial unit for support. Half of the responders were interested in recurrent paediatric Good Clinical Practice training. Doctors responded that clinical work often had to be prioritised and emphasised the need for research time. Conclusion: This study clearly shows the commitment for clinical trials among doctors and nurses involved in paediatric care in Sweden, but also that administrative, logistic and economic support in a sustainable setting and an expanded national collaboration are needed.
(Less)
- author
- Mattsson, Hanna ; Kindblom, Jenny M. ; Norman, Elisabeth LU ; Rane, Anders and Naumburg, Estelle
- organization
- publishing date
- 2020-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- child, clinical trials, drug development, infrastructure, paediatrics
- in
- Acta Paediatrica, International Journal of Paediatrics
- volume
- 109
- issue
- 12
- pages
- 8 pages
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:85082625036
- pmid:32171036
- ISSN
- 0803-5253
- DOI
- 10.1111/apa.15254
- language
- English
- LU publication?
- yes
- id
- 74181159-7daf-4e31-aeac-b53f7ad13a7b
- date added to LUP
- 2020-04-27 16:10:20
- date last changed
- 2024-04-03 06:09:02
@article{74181159-7daf-4e31-aeac-b53f7ad13a7b,
abstract = {{<p>Aim: There is a lack of authorised medicines for paediatric patients and improved drug development is necessary. The aim of this study was to evaluate the need for infrastructure and support for paediatric clinical trials in Sweden. Methods: A web-based survey was sent to doctors and nurses involved in the care of neonates, children and adolescents assessing the current situation and future needs for paediatric clinical trials in Sweden. Questions regarding premises, competence, organisation, support for paediatric clinical trials and Good Clinical Practice Training were addressed. Results: In total, 137 individuals responded to the survey (109 doctors and 28 nurses). Overall, 61% of the respondents had previous experience of paediatric clinical trials. Some respondents had access to trial units, but only 34% had used the trial unit for support. Half of the responders were interested in recurrent paediatric Good Clinical Practice training. Doctors responded that clinical work often had to be prioritised and emphasised the need for research time. Conclusion: This study clearly shows the commitment for clinical trials among doctors and nurses involved in paediatric care in Sweden, but also that administrative, logistic and economic support in a sustainable setting and an expanded national collaboration are needed.</p>}},
author = {{Mattsson, Hanna and Kindblom, Jenny M. and Norman, Elisabeth and Rane, Anders and Naumburg, Estelle}},
issn = {{0803-5253}},
keywords = {{child; clinical trials; drug development; infrastructure; paediatrics}},
language = {{eng}},
number = {{12}},
pages = {{2740--2747}},
publisher = {{Wiley-Blackwell}},
series = {{Acta Paediatrica, International Journal of Paediatrics}},
title = {{Improved infrastructure and support needed for paediatric clinical trials in Sweden}},
url = {{http://dx.doi.org/10.1111/apa.15254}},
doi = {{10.1111/apa.15254}},
volume = {{109}},
year = {{2020}},
}